Full Text Journal Articles by
Author Jae Weon Kim

Advertisement

Find full text journal articles






Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.

Se Ik Kim, Tae Hun Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Taek Sang Lee, Hye Won Jeon, Jae Weon Kim, Noh Hyun Park, Yong Sang Song,

<h4>Purpose</h4>To determine whether the prognostic impact of lymph node ratio (LNR), defined as the ratio between the number of positive lymph nodes and removed lymph nodes, differs between open and minimally invasive surgical approaches for radical hysterectomy (RH) in node-positive, early-stage cervical cancer.<h4>Materials and methods</h4>We retrospectively identified 2009 International Federation ... Read more >>

Yonsei Med J (Yonsei medical journal)
[2021, 62(3):231-239]

Cited: 0 times

View full text PDF listing >>



Post-LACC era: critical assessment not "all-or-none" is needed.

Mario M Leitao, Se Ik Kim, Jae Weon Kim,

J Gynecol Oncol (Journal of gynecologic oncology)
[2021, 32(2):e47]

Cited: 0 times

View full text PDF listing >>



Advertisement

Time for enhancing government-led primary prevention of cervical cancer.

Kyung Jin Min, Dong Hoon Suh, Tsukasa Baba, Xiaojun Chen, Jae Weon Kim, Yusuke Kobayashi, Janice Kwon, Myong Cheol Lim, Jung Yun Lee, Satoru Nagase, Jeong Yeol Park, Siriwan Tangjitgamol, Hidemichi Watari,

J Gynecol Oncol (Journal of gynecologic oncology)
[2021, 32(1):e12]

Cited: 0 times

View full text PDF listing >>



Erratum: Author Correction. Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea.

Yusuke Kobayashi, Dong Hoon Suh, Kosuke Tsuji, Jin Young Kim, Sojin Shin, Daisuke Aoki, Jae Weon Kim,

This corrects the article on p. e65 in vol. 31, PMID: 32342678. ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2020, 31(5):e87]

Cited: 0 times

View full text PDF listing >>



Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.

Rong Jiang, Jianqing Zhu, Jae Weon Kim, Jihong Liu, Kazuyoshi Kato, Hee Seung Kim, Yuqin Zhang, Ping Zhang, Tao Zhu, Daisuke Aoki, Aijun Yu, Xiaojun Chen, Xipeng Wang, Ding Zhu, Wei Zhang, Huixun Jia, Tingyan Shi, Wen Gao, Sheng Yin, Yanling Feng, Libing Xiang, Aikou Okamoto, Rongyu Zang,

<h4>Background</h4>Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection and lack of surgical qualifications for participating centers. There is no consensus on whether neoadjuvant chemotherapy ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2020, 31(5):e86]

Cited: 0 times

View full text PDF listing >>



Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.

Andrés Poveda, Anne Floquet, Jonathan A Ledermann, Rebecca Asher, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Sandro Pignata, Michael Friedlander, Alessandra Baldoni, Tjoung-Won Park-Simon, Kenji Tamura, Gabe S Sonke, Alla Lisyanskaya, Jae-Hoon Kim, Elias Abdo Filho, Tsveta Milenkova, Elizabeth S Lowe, Phil Rowe, Ignace Vergote, Eric Pujade-Lauraine, ,

<h4>Background</h4>Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously been shown to extend progression-free survival versus placebo when given to patients with relapsed high-grade serous or endometrioid ovarian cancer who were platinum sensitive and who had a BRCA1 or BRCA2 (BRCA1/2) mutation, as part of the SOLO2/ENGOT-Ov21 trial. The aim ... Read more >>

Lancet Oncol (The Lancet. Oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Development of Rotational Intraperitoneal Pressurized Aerosol Chemotherapy to Enhance Drug Delivery into the Peritoneum

Soo Jin Park, Eun Ji Lee, Hee Su Lee, Junsik Kim, Sunwoo Park, Jiyeon Ham, Jaehee Mun, Haerin Paik, Hyunji Lim, Aeran Seol, Ga Won Yim, Seung-Hyuk Shim, Beong-Cheol Kang, Suk Joon Chang, Whasun Lim, Gwonhwa Song, Jae Weon Kim, Nara Lee, Jung Chan Lee, Hee Seung Kim,

<h4>Background: </h4> Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as palliative therapy for treating peritoneal metastasis (PM) of solid tumors. However, restricted use in the limited countries and the uneven distribution and penetration in various regions of the peritoneal cavity ac as disadvantages of PIPAC. Thus, the KOrean Rotational ... Read more >>

()
[, :]

Cited: 0 times

View full text PDF listing >>



Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.

Jean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, Mark Carey, Iwa Kong, Rosalind M Glasspool, Jonathan S Berek, Mariana de Paiva Batista, Marcia Hall, Jae-Weon Kim, Effi Yeoshoua, Noriko Fujiwara, Byung-Ho Nam, Sandra Polleis, Jung-Yun Lee, Aleksandra Strojna, Laura Farrelly, Richard Schwameis, Roldano Fossati, Anne-Sophie Darlington, Chyong-Huey Lai, Alexi A Wright, Orgad Rosenblat, Phillip Harter, Patricia Roxburgh, Rahul Roy Chowdhury, Ting-Chang Chang, Xavier Paoletti, Michael Friedlander, ,

<h4>Background</h4>Quality of life and patient reported outcome measures (PROMs) are important secondary endpoints and incorporated in most contemporary clinical trials. There have been deficiencies in their assessment and reporting in ovarian cancer clinical trials, particularly in trials of maintenance treatment where they are of particular importance. The Gynecologic Cancer InterGroup ... Read more >>

Gynecol Oncol (Gynecologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Major clinical research advances in gynecologic cancer in 2019.

Miseon Kim, Dong Hoon Suh, Kyung Hun Lee, Keun Yong Eom, Jung Yun Lee, Yoo Young Lee, Hanne Falk Hansen, Mansoor Raza Mirza, Jae Weon Kim,

In 2019, 12 topics were selected as the major research advances in gynecologic oncology. Herein, we first opted to introduce the significant clinical activity of pembrolizumab in women with advanced cervical cancer based on the results of the phase 2 KEYNOTE-158 trial. Thereafter, we reviewed 5 topics, including systemic lymphadenectomy ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2020, 31(3):e48]

Cited: 2 times

View full text PDF listing >>



Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea.

Yusuke Kobayashi, Dong Hoon Suh, Daisuke Aoki, Jae Weon Kim,

J Gynecol Oncol (Journal of gynecologic oncology)
[2020, 31(3):e65]

Cited: 4 times

View full text PDF listing >>



Ultra-radical surgery in ovarian cancer.

Sang-Yoon Park, Jae-Weon Kim,

Gland Surg (Gland surgery)
[2021, 10(3):1171-1172]

Cited: 0 times

View full text PDF listing >>



Endometrial Cancer.

Se-Ik Kim, Jae-Weon Kim,

N Engl J Med (The New England journal of medicine)
[2021, 384(6):586]

Cited: 0 times

View full text PDF listing >>



Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.

Robert D Morgan, Iain A McNeish, Adrian D Cook, Elizabeth C James, Rosemary Lord, Graham Dark, Rosalind M Glasspool, Jonathan Krell, Christine Parkinson, Christopher J Poole, Marcia Hall, Dolores Gallardo-Rincón, Michelle Lockley, Sharadah Essapen, Jeff Summers, Anjana Anand, Abel Zachariah, Sarah Williams, Rachel Jones, Kate Scatchard, Axel Walther, Jae-Weon Kim, Sudha Sundar, Gordon C Jayson, Jonathan A Ledermann, Andrew R Clamp,

<h4>Background</h4>Platinum-based neoadjuvant chemotherapy followed by delayed primary surgery (DPS) is an established strategy for women with newly diagnosed, advanced-stage epithelial ovarian cancer. Although this therapeutic approach has been validated in randomised, phase 3 trials, evaluation of response to neoadjuvant chemotherapy using Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST), ... Read more >>

Lancet Oncol (The Lancet. Oncology)
[2021, 22(2):277-288]

Cited: 0 times

View full text PDF listing >>



Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles.

Se Ik Kim, Woo Yeon Hwang, Maria Lee, Hee Seung Kim, Kidong Kim, Hyun Hoon Chung, Jae Hong No, Jae-Weon Kim, Yong Beom Kim, Noh Hyun Park, Yong-Sang Song, Dong Hoon Suh,

<h4>Background</h4>To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemotherapy.<h4>Methods</h4>In this study, 135 EOC patients who experienced platinum-sensitive recurrence after primary treatment between 2008 and 2018, and had a residual tumor ≥0.5 cm (detected ... Read more >>

BMC Cancer (BMC cancer)
[2020, 20(1):1199]

Cited: 0 times

View full text PDF listing >>



Asian perspective on debulking surgery for advanced ovarian cancer: An E-survey.

Soo Jin Park, Eun Ji Lee, Taek Sang Lee, Kung-Liahng Wang, Aikou Okamoto, Kazunori Ochiai, Hee Seung Kim, Jae-Weon Kim,

<h4>Purpose</h4>We performed an E-survey to evaluate the practice patterns in debulking surgery for advanced ovarian cancer in Asia.<h4>Methods</h4>We designed a questionnaire, including 50 questions related to debulking surgery for advanced ovarian cancer. The questionnaire was sent to Gynecologic Oncologic Groups in Asia from December 2016 to February 2017.<h4>Results</h4>A total of ... Read more >>

Eur J Surg Oncol (European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy.

Se Ik Kim, Tae Hun Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Taek Sang Lee, Hye Won Jeon, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song,

This study aimed to investigate the impact of adjuvant radiotherapy (RT) on survival outcomes in patients with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy (RH). From the cervical cancer cohorts of two tertiary hospitals, patients with 2009 FIGO stage IB-IIA who underwent primary RH between 2010 and 2018 were ... Read more >>

J Clin Med (Journal of clinical medicine)
[2020, 9(11):]

Cited: 0 times

View full text PDF listing >>



High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology.

Tae Wook Kong, Miseon Kim, Young Han Kim, Yong Beom Kim, Jayeon Kim, Jae Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon Seok Hong,

Based on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology support the following scientific facts: • Compared to cytology, hrHPV screening has higher sensitivity and detects ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2020, 31(1):e31]

Cited: 1 time

View full text PDF listing >>



Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer.

Se Ik Kim, Eun Ji Lee, Maria Lee, Hyunhoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Hee Seung Kim,

<h4>Objective</h4>Evidence on recurrence patterns after bevacizumab in epithelial ovarian cancer is still insufficient. The aim of this study was to evaluate recurrence patterns after treatment with bevacizumab as second-line treatment in patients with platinum-sensitive, recurrent epithelial ovarian cancer.<h4>Methods</h4>We retrospectively identified epithelial ovarian cancer patients who relapsed ≥6 months after primary ... Read more >>

Int J Gynecol Cancer (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society)
[2020, 30(12):1943-1950]

Cited: 0 times

View full text PDF listing >>



Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy.

Angelina Tjokrowidjaja, Chee K Lee, Michael Friedlander, Val Gebski, Laurence Gladieff, Jonathan Ledermann, Richard Penson, Amit Oza, Jacob Korach, Tomasz Huzarski, Luis Manso, Carmela Pisano, Rebecca Asher, Sarah J Lord, Se Ik Kim, Jung-Yun Lee, Nicoletta Colombo, Tjoung-Won Park-Simon, Keiichi Fujiwara, Gabe Sonke, Ignace Vergote, Jae-Weon Kim, Eric Pujade-Lauraine,

<h4>Background</h4>Limited evidence exists to support CA-125 as a valid surrogate biomarker for progression in patients with ovarian cancer on maintenance PARP inhibitor (PARPi) therapy. We aimed to assess the concordance between CA-125 and Response Evaluation Criteria in Solid Tumours (RECIST) criteria for progression in patients with BRCA mutations on maintenance ... Read more >>

Eur J Cancer (European journal of cancer (Oxford, England : 1990))
[2020, 139:59-67]

Cited: 1 time

View full text PDF listing >>



Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement.

Miseon Kim, Tae Wook Kong, Sunghoon Kim, Seung Cheol Kim, Yong Beom Kim, Jae Weon Kim, Jeong Yeol Park, Dong Hoon Suh, Seung Hyuk Shim, Keun Ho Lee, Sung Jong Lee, Jae Kwan Lee, Myong Cheol Lim,

On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2019, 30(5):e104]

Cited: 2 times

View full text PDF listing >>



After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey.

Miseon Kim, Yong Beom Kim, Jae Weon Kim,

J Gynecol Oncol (Journal of gynecologic oncology)
[2019, 30(5):e108]

Cited: 0 times

View full text PDF listing >>



Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.

Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song,

<h4>Purpose</h4>This study aimed to present a single institutional experience with BRCA1/2 gene tests and the effects of pathogenic mutations in epithelial peritoneal, ovarian, and fallopian tube cancer (POFTC) on survival outcomes.<h4>Materials and methods</h4>We identified patients with epithelial POFTCs who underwent BRCA1/2 gene testing by either germline or somatic methods between ... Read more >>

Cancer Res Treat (Cancer research and treatment)
[2020, 52(4):1229-1241]

Cited: 0 times

View full text PDF listing >>



The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report.

Ga Won Yim, Dong Hoon Suh, Jae Weon Kim, Seung Cheol Kim, Young Tae Kim,

The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2019, 30(4):e91]

Cited: 1 time

View full text PDF listing >>



A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA).

Natalie Yl Ngoi, Valerie Heong, Samuel Ow, Wen Yee Chay, Hee Seung Kim, Chel Hun Choi, Geraldine Goss, Jeffrey C Goh, Bee Choo Tai, Diana Gz Lim, Nivashini Kaliaperumal, Veonice B Au, John E Connolly, Jae-Weon Kim, Michael Friedlander, Kidong Kim, David Sp Tan,

<h4>Background</h4>The optimal treatment of recurrent ovarian clear cell carcinoma remains unknown. There is increasing rationale to support the role of immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD<i>-</i>1)/programmed death-ligand 1 (PD-L1) axis in ovarian clear cell carcinoma.<h4>Primary objective</h4>To evaluate the efficacy of durvalumab (MEDI-4736) compared with standard ... Read more >>

Int J Gynecol Cancer (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society)
[2020, 30(8):1239-1242]

Cited: 1 time

View full text PDF listing >>



Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.

Sarah P Blagden, Adrian D Cook, Christopher Poole, Lesley Howells, Ian A McNeish, Andrew Dean, Jae-Weon Kim, Dearbhaile M O'Donnell, Jane Hook, Elizabeth C James, Ian R White, Timothy Perren, Rosemary Lord, Graham Dark, Helena M Earl, Marcia Hall, Richard Kaplan, Jonathan A Ledermann, Andrew R Clamp,

<h4>Background</h4>The ICON8 study reported no significant improvement in progression-free survival (a primary endpoint) with weekly chemotherapy compared with standard 3-weekly treatment among patients with epithelial ovarian cancer. All ICON8 patients were eligible to take part in the accompanying health-related quality-of-life study, which measured the effect of treatment on self-reported wellbeing, ... Read more >>

Lancet Oncol (The Lancet. Oncology)
[2020, 21(7):969-977]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.0121 s